GS-9450

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GS-9450, covering 2014-02-04 to 2014-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV [Phase 2]

See pricing